Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

JSPR Jasper Therapeutics

Market Closed 06-26 16:00:00 EDT

0.3410

-0.1018

-22.99%

盘后0.3500

+0.0090+2.64%

19:59 EDT

High0.4537	Low0.3400	Vol1.35M
Open0.4401	D1 Closing0.4428	Amplitude25.68%
Mkt Cap9.54M	Tradable Cap7.78M	Total Shares27.98M
T/O502.71K	T/O Rate5.93%	Tradable Shares22.81M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"JSPR","market":"US","secType":"STK","nameCN":"Jasper Therapeutics","latestPrice":0.341,"timestamp":1782504000000,"preClose":0.4428,"halted":0,"volume":1352434,"hourTrading":{"tag":"盘后","latestPrice":0.35,"preClose":0.341,"latestTime":"19:59 EDT","volume":87601,"amount":29908.040631,"timestamp":1782518383169,"change":0.009,"changeRate":0.026393,"amplitude":0.068035},"delay":0,"changeRate":-0.2299006323396567,"floatShares":22810300,"shares":27984039,"eps":-2.469679,"marketStatus":"Market Closed","change":-0.1018,"latestTime":"06-26 16:00:00 EDT","open":0.4401,"high":0.4537,"low":0.34,"amount":502705.6685096,"amplitude":0.256775,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.469679,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782720000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4428,"preHourTrading":{"tag":"盘前","latestPrice":0.44,"preClose":0.4428,"latestTime":"08:53 EDT","volume":188,"amount":83.3205002,"timestamp":1782478427792,"change":-0.0028,"changeRate":-0.006323,"amplitude":0.067751},"postHourTrading":{"tag":"盘后","latestPrice":0.35,"preClose":0.341,"latestTime":"19:59 EDT","volume":87601,"amount":29908.040631,"timestamp":1782518383169,"change":0.009,"changeRate":0.026393,"amplitude":0.068035},"volumeRatio":2.1043677994089096,"impliedVol":2.8157,"impliedVolPercentile":0.8765},"requestUrl":"/m/hq/s/JSPR","defaultTab":"news","newsList":[{"id":"2643333785","title":"Jasper Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2643333785","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643333785?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:04","pubTimestamp":1781553871,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics will hold its annual stockholders meeting virtually on July 31, 2026.Items up for a vote include electing two Class II directors to terms running to the 2029 annual meeting.An advisory vote on named executive officer compensation is also scheduled.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL4CCf4N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642349201","title":"Jasper Therapeutics -  on June 3, 2026, Co Receives Nasdaq Notice for Minimum Bid Price Non-Compliance - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2642349201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642349201?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:07","pubTimestamp":1781035671,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42H0Q8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642149202","title":"Jasper Therapeutics gets Nasdaq notice after shares trade below $1 bid-price minimum","url":"https://stock-news.laohu8.com/highlight/detail?id=2642149202","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642149202?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:07","pubTimestamp":1781035639,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics received a Nasdaq notice for failing the $1 minimum bid rule after 30 consecutive business days below $1.Granted 180 days to regain compliance by Nov. 30, 2026; compliance requires a closing bid of at least $1 for 10 straight sessions.Shares and public warrants continue trading on Nasdaq Capital Market under JSPR, JSPRW; no immediate impact on listing.Noncompliance by the deadline could trigger delisting risk; a second 180-day cure period may be available, potentially via reverse stock split.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL95L7Q0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641126868","title":"Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2641126868","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641126868?lang=en_us&edition=fundamental","pubTime":"2026-06-06 01:14","pubTimestamp":1780679640,"startTime":"0","endTime":"0","summary":"Major M&A deals this week include: New Mountail Capital buys Asset Living, SalesForce acquires Contentful, Wellington nabs The Hartford Funds","market":"sh","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/06/05/benzinga-deal-dispatch2.jpeg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,dpr=2,format=auto,quality=85/files/images/story/2026/06/05/benzinga-deal-dispatch2.jpeg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/m-a/26/06/53036552/deal-dispatch-jasper-therapeutics-for-sale-robinhood-completes-180-million-wonderfi-acquisition-long-john-silvers-franchisee-to-liquidate","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/m-a/26/06/53036552/deal-dispatch-jasper-therapeutics-for-sale-robinhood-completes-180-million-wonderfi-acquisition-long-john-silvers-franchisee-to-liquidate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["JSPR","USJW.SI","IE0004091025.USD","GOOY","LU0130102774.USD","GOU","SG9999015945.SGD","LU0426412945.USD","LU0310799852.SGD","LU0965508806.USD","LU0820561818.USD","GOOG","GOOP","LU2125154935.USD","HK0000819398.USD","IE000SO60NU8.SGD","GGLL","LU0096364046.USD","LU2237443978.SGD","YMAG","IE00B7KXQ091.USD","GOOW","NVDA","LU0289961442.SGD","GOOGL","LU0444971666.USD","LU0557290698.USD","SETM","LU0661504455.SGD","LU0208291251.USD","LU2462157665.USD","LU1116320901.HKD","MAGY","META","GGLS","WTAI","AMZN","SOCL","TSLA","HK0000532082.HKD","MSFT","AAPL","LU0792757196.USD","LU2764263039.SGD","LU0068578508.USD","GOOX","SG9999000418.SGD","LU2404859741.USD","LU2456880835.USD","LU0784384876.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640966749","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jasper Therapeutics (JSPR) and Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640966749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640966749?lang=en_us&edition=fundamental","pubTime":"2026-06-02 02:00","pubTimestamp":1780336841,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Jasper Therapeutics (JSPR) and Corbus Pharmaceutic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-jasper-therapeutics-jspr-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-jasper-therapeutics-jspr-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JSPR","BK4581","XLV","BK4588","LU0128526141.USD","BK4585","HCSG","XBI","BK4139","CRBP","LABU","LU0029874061.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640177966","title":"Sector Update: Healthcare Stocks Fall in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2640177966","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640177966?lang=en_us&edition=fundamental","pubTime":"2026-06-02 01:49","pubTimestamp":1780336181,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Monday afternoon, with the NYSE Healthcare Index falling 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) dropping 1.4%.The iShares Biotechnology ETF (IBB)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014005.SGD","BK4585","LU0266013472.USD","LU1093756325.SGD","XLV","LU0238689110.USD","LU1093756168.USD","LU1983260115.SGD","LU0029874061.USD","BK4581","BK4007","BK4154","BK4139","BK7500","EWTX","BK4566","BK4588","LU0348723411.USD","GRAL","LU0070302665.USD","IBB","LU0320765489.SGD","BK4137","XBI","LU0256863811.USD","LU0417517546.SGD","SG9999014021.USD","SG9999014013.SGD","LABU","HCSG","BK4539","LU0208291251.USD","LU0211331839.USD","LU0128526141.USD","BK7093","BK4533","HUM.AU","LU0170899867.USD","LU0390134368.USD","HUM","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640696353","title":"BUZZ-U.S. STOCKS ON THE MOVE-Apple, JetBlue, Cognizant","url":"https://stock-news.laohu8.com/highlight/detail?id=2640696353","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640696353?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:43","pubTimestamp":1780328602,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Apple, JetBlue, CognizantWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nL6N4290Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEG","CEGX","FDX","AAPW","MACW.SI","QCOM","QCML","AMDL","AAPU","FRDU","DAMD","AAPY","AAPD","AAPL","AMDD","TMHC","AMYY","AMD","EWTX","AAPB","MGM","CMI","OXY","ADBE","INTC","QCMU","JSPR","AMDY","AMUU","JBLU","NOW","DVN","TEAM","APLY","AAPX","AMC","GPRK","LINT","AMDW","IBIT","SPCE","NOWL","XOMO","RVMD","F","XOM","ADBG","IBM","GM","CVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640954365","title":"Jasper Therapeutics Explores Sale, Merger and Other Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2640954365","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640954365?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:49","pubTimestamp":1780318148,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics  said Monday that its board has launched a comprehensive review of strategic alternatives, including a potential sale of assets, licensing deals, collaborations, merger, business combination, sale of the company or an orderly wind-down of operations.The clinical-stage biotech company, which is developing briquilimab for mast cell-driven diseases, said it is also evaluating cost-saving measures to preserve cash while maintaining regulatory and financial reporting compliance.Jasper noted there is no set timeline for the review process and no assurance that it will result in a transaction or other strategic outcome.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959721","title":"Jasper Therapeutics explores strategic alternatives, including asset sale or merger, to maximize shareholder value","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959721","media":"Reuters","labels":["merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959721?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:05","pubTimestamp":1780315539,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics launched a comprehensive review of strategic alternatives to maximize shareholder value.Options under evaluation include asset sales or licensing, partnerships, a company sale, or a merger or other strategic transaction.Management will pursue additional cost cuts to preserve cash while maintaining regulatory and financial reporting compliance.No timeline was set for the review, with no assurance a transaction will be announced or completed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL4Wlhsn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640959171","title":"Jasper Therapeutics - Options Include Asset Sale, Licensing, Collaborations, Company Sale, Merger, or Wind-Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2640959171","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640959171?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:00","pubTimestamp":1780315203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUA93LQJN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640591019","title":"Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2640591019","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640591019?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:00","pubTimestamp":1780315203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUA93LQJN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637570353","title":"Jasper Therapeutics Announces Board Resignation and Committee Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2637570353","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637570353?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:40","pubTimestamp":1779399616,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics ( ($JSPR) ) just unveiled an announcement. On May 15, 2026, Jasper Therapeutics, Inc. announced that board member Christian Nol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-announces-board-resignation-and-committee-change?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-announces-board-resignation-and-committee-change?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637351187","title":"Jasper Therapeutics director Christian Nolet resigns from board","url":"https://stock-news.laohu8.com/highlight/detail?id=2637351187","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637351187?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:02","pubTimestamp":1779393734,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics disclosed that director Christian Nolet resigned from the board and its committees, effective May 15, 2026.The resignation was not tied to any disagreement over the company’s operations, policies, or practices.Svetlana Lucas was appointed to the board’s audit committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL18K3wv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635038400","title":"Jasper Therapeutics Is Maintained at Sector Perform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2635038400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635038400?lang=en_us&edition=fundamental","pubTime":"2026-05-15 22:13","pubTimestamp":1778854380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JSPR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 15, 2026 10:13 ET (14:13 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0029864427.USD","LU0708994859.HKD","LU0128525929.USD","LU0310800379.SGD","LU1267930573.SGD","JSPR","BK4207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087033","title":"Jasper Therapeutics price target lowered to $3 from $4 at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087033?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:18","pubTimestamp":1778851093,"startTime":"0","endTime":"0","summary":"RBC Capital lowered the firm’s price target on Jasper Therapeutics (JSPR) to $3 from $4 and keeps a Sector Perform rating on the shares. The firm c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-price-target-lowered-to-3-from-4-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-price-target-lowered-to-3-from-4-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089816","title":"TD Cowen Downgrades Jasper Therapeutics to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089816","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089816?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:22","pubTimestamp":1778844123,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics (JSPR) has an average rating of overweight and mean price target of $9.08, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JSPR","TD","COWN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635088655","title":"Jasper Therapeutics Inc : TD Cowen Cuts to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2635088655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635088655?lang=en_us&edition=fundamental","pubTime":"2026-05-15 18:03","pubTimestamp":1778839396,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S0Q3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635006317","title":"Jasper Therapeutics downgraded to Hold from Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2635006317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635006317?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:40","pubTimestamp":1778838009,"startTime":"0","endTime":"0","summary":"TD Cowen downgraded Jasper Therapeutics (JSPR) to Hold from Buy without a price target The company is “now at a critical juncture,” the analyst tel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-downgraded-to-hold-from-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-downgraded-to-hold-from-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COWN","JSPR","TD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635721200","title":"Jasper Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635721200","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635721200?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:55","pubTimestamp":1778795752,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryJasper Therapeutics Inc JSPR.OQ reported a quarterly adjusted loss of 32 cents per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R2NA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635472377","title":"Jasper Therapeutics Q1 net loss narrows 94% to $1.17 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635472377","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635472377?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:12","pubTimestamp":1778789551,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics posted a net loss of USD 1.17 million for the quarter ended March 31, 2026, narrowing 94% from the year-ago period.Operating loss narrowed 50% to USD 10.95 million, while total operating expenses fell 50% to USD 10.95 million.Research and development expense dropped 64% to USD 5.81 million, while general and administrative costs eased 9% to USD 5.14 million.Total other income climbed to USD 9.78 million from USD 561,000, driven by a USD 9.64 million gain from change in fair value of warrant liability.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDLbhFhDk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jaspertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.2472},{"period":"1month","weight":-0.6221},{"period":"3month","weight":-0.6752},{"period":"6month","weight":-0.8063},{"period":"1year","weight":-0.9401},{"period":"ytd","weight":-0.8137}],"compareEarnings":[{"period":"1week","weight":-0.0238},{"period":"1month","weight":-0.0286},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.056},{"period":"1year","weight":0.1914},{"period":"ytd","weight":0.069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.285776},{"month":2,"riseRate":0.428571,"avgChangeRate":0.093912},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.063229},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.031704},{"month":5,"riseRate":0.714286,"avgChangeRate":0.025166},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.164728},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.099771},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007485},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.2127},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.027786},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.069737},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.008174}],"exchange":"NASDAQ","name":"Jasper Therapeutics","nameEN":"Jasper Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jasper Therapeutics(JSPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jasper Therapeutics,JSPR,Jasper Therapeutics股票,Jasper Therapeutics股票老虎,Jasper Therapeutics股票老虎国际,Jasper Therapeutics行情,Jasper Therapeutics股票行情,Jasper Therapeutics股价,Jasper Therapeutics股市,Jasper Therapeutics股票价格,Jasper Therapeutics股票交易,Jasper Therapeutics股票购买,Jasper Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jasper Therapeutics(JSPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}